TX-NEOS-THERAPEUTICS
Neos Therapeutics, Inc. (“Neos” or “the Company”), a highly differentiated oral drug delivery company with a portfolio of proprietary technologies and a late-stage pipeline of innovative controlled release (CR) products for ADHD, announced today that it has been granted a patent covering its novel amphetamine ADHD products.
Neos has developed an extended release (XR) amphetamine oral disintegrating tablet (ODT) and an extended release amphetamine liquid suspension both of which are expected to be filed for FDA approval in the next 12-15 months. “We are pleased with the grant of this patent as it will provide protection for our amphetamine XR-ODT and amphetamine XR-suspension until June 2032,” said Vipin K. Garg, Ph.D., Chief Executive Officer of Neos. “We have begun to assess our options to commercialize these products in anticipation of FDA approval.”
“The Neos patent portfolio continues to grow as we continue to develop and utilize our platform drug delivery technologies,” stated Mark Tengler, Chief Technology Officer of Neos. “Extended release and patient-friendly dosage forms are essential in the treatments of ADHD, and our technologies may provide this advantage.”
About Neos Therapeutics
Neos Therapeutics Inc., is a specialty pharmaceutical company focused on the development and manufacture of FDA approved drug products that utilize the Company’s proprietary and patented delivery technologies. The Neos drug products are being developed using the Dynamic Time Release Suspension® (DTRS®) and Rapidly Disintegrating Ionic Masking™ (RDIM™) technologies that deliver controlled release (CR) small molecule active pharmaceutical ingredients (APIs) in either liquid or orally disintegrating tablet (ODT) dosage forms. By utilizing APIs that are already FDA-approved, Neos can reduce development and regulatory risk and efficiently advance targeted proprietary Rx products through the FDA’s New Drug Application (NDA) approval process. For more information, visit www.neostx.com .
Dynamic Time Release Suspension® and DTRS® are registered trademarks of Neos Therapeutics, LP, an affiliate of Neos Therapeutics, Inc., and Rapidly Disintegrating Ionic Masking™ and RDIM™ are trademarks of Neos Therapeutics, Inc.
This press release contains certain “forward-looking statements” that include projections and may also include words such as “may”, “will”, “expects”, “believes”, “anticipates”, “plans”, “estimates”, “seeks”, “could”, “intends”, and other similar expressions. These forward-looking statements involve risks, uncertainties, assumptions and other factors that are difficult to predict and that could cause actual results to vary materially from what is expressed in or indicated by the forward-looking statements.
Contact:
Neos Therapeutics, Inc.
Vipin K. Garg, Ph.D.
Chief Executive
Officer
(919) 434-6643
vgarg@neostx.com
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Megaport Surpasses 1,000 Enabled Locations Worldwide7.8.2025 22:00:00 CEST | Press release
Megaport now provides access from 10% of all data centres worldwide, making it the world’s leading Network as a Service provider. Megaport Limited (ASX: MP1) (“Megaport”), the global leading Network as a Service (NaaS) provider, announced today that it has launched its 1,000th Megaport-enabled location. With this milestone, Megaport now provides access from 10% of all public data centres worldwide, making it the world’s leading vendor-neutral NaaS connectivity platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250807394677/en/ With over 1,000 enabled locations, Megaport now provides access from 10% of all data centres worldwide. From its start as a disruptor in the connectivity space, Megaport has now become the go-to solution for IT teams needing fast, flexible, and secure interconnection between cloud services, data centres, and enterprise sites. The Company’s global reach now spans over 160 cities across 26 countrie
Andersen Consulting indgår samarbejdsaftale med Systematix7.8.2025 21:38:00 CEST | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation og cybersikkerhed med tilføjelsen af samarbejdspartneren Systematix, et førende teknologikonsulentfirma, der er kendt for at levere innovative digitale løsninger, der bidrager til operationel effektivitet, vækst og konkurrencemæssige fordele. Systematix blev stiftet i 1975 og tilbyder komplette konsulent- og implementeringstjenester inden for digital transformation, udvikling af virksomhedsapplikationer, ERP, forretningsanalyse, it-strategi og cybersikkerhed. Med hundredvis af erfarne konsulenter og teknologer hjælper Systematix deres kunder med at navigere i komplekse forretningsmæssige udfordringer ved hjælp af nye teknologier og tilbyder skalerbare løsninger til en række robuste brancher, herunder finanssektoren, sundhedsvæsenet, produktionsvirksomheder og organisationer i den offentlige sektor. "I de sidste fem årtier har vi opbygget et omdømme for at levere robuste teknologiløsninger og ressourcer, der h
Lyten to Acquire All Remaining Northvolt Assets in Sweden and Germany7.8.2025 18:24:00 CEST | Press release
Lyten, the global leader in lithium-sulfur batteries, announced it has entered into binding agreements to acquire Northvolt Ett and Ett Expansion, Northvolt Labs, Northvolt Drei, and all remaining Northvolt intellectual property (IP). These newly acquired assets were previously valued at approximately $5B and include 16 GWh of operational battery production capacity and over 15 GWh under construction. Lyten has expressed interest in additionally acquiring Northvolt Six in Quebec, Canada. Lyten plans to restart operations at Northvolt Ett and Northvolt Labs upon close of the transaction, which is being fully funded with equity investment. Lyten, the global leader in lithium-sulfur batteries, announced today that it has entered into a binding agreement to acquire Northvolt’s remaining assets in Sweden and Germany. The acquisition includes Northvolt Ett and Ett Expansion (Skellefteå, Sweden), Northvolt Labs (Västerås, Sweden), and Northvolt Drei (Heide, Germany). Additionally, Lyten is ac
Energy Vault Secures Final FIRB Approval and Completes Acquisition of 125 MW/1,000 MWh Stoney Creek BESS in Australia7.8.2025 15:15:00 CEST | Press release
Stoney Creek represents first acquisition in Australia as part of Energy Vault’s global “Own & Operate” portfolio and reinforces long-term commitment to Australia’s energy transition125 MW/1,000 MWh Stoney Creek BESS set to support grid reliability and flexibility while advancing the energy transition in New South Wales, supported by a 14-year offtake agreementStoney Creek is Energy Vault’s third and largest Energy Storage Asset in the portfolio, following the successful completion of the Cross Trails BESS in Texas and Calistoga Resiliency Center in California, and is expected to deliver ~$30 million in combined annual, recurring EBITDA for the next 15+ years Energy Vault Holdings, Inc. (NYSE: NRGV) ("Energy Vault"), a global leader in grid-scale energy storage solutions, today announced it has received Foreign Investment Review Board (FIRB) approval and completed the full acquisition of the Stoney Creek Battery Energy Storage System (BESS) project in Northern New South Wales. The 125
Museum Centre Vapriikki:Ancient DNA Reveals 800-year-old Family Link in Medieval Finland7.8.2025 14:05:00 CEST | Press release
Ancient DNA research led by the Museum Centre Vapriikki in Tampere, Finland, in collaboration with the universities of Turku and Helsinki, has produced new insights into kinship, health, and population continuity in medieval and early modern Finland. Published in the peer-reviewed journal iScience, the research presents results from 25 individuals in Finland – a significant result in a country where acidic soils often lead to poor preservation of bones and genetic material. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250807066724/en/ The woman’s grave in Vilusenharju, Tampere was discovered in 1962, and the man’s grave in Ristiänmäki, Pälkäne in 1982. Ancient DNA research has now revealed that the deceased were siblings. Illustrations by Veronika Paschenko. Photo by Vapriikki. Researchers successfully recovered DNA from individuals buried between the 12th and 19th centuries at three cemeteries in the Tampere region. The s
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum